FierceBiotech 27 mai 2026 D&D sees fibrosis improvements, MASH resolution after rolling dice on GLP-1 drug
FierceBiotech 27 mai 2026 Insulet issues voluntary correction for Omnipod devices in leaky insulin fault
FierceBiotech 27 mai 2026 Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3
FierceBiotech 27 mai 2026 FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
FierceBiotech 26 mai 2026 As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
FierceBiotech 26 mai 2026 Kura posts Krazati combo data on drug designed to unleash KRAS inhibitors’ potential
FierceBiotech 26 mai 2026 Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues
FierceBiotech 26 mai 2026 Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs
FierceBiotech 25 mai 2026 Lilly preps for ph. 2 launch after Verve gene editor cuts cholesterol on par with PCSK9 inhibitors
FierceBiotech 22 mai 2026 Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both
FierceBiotech 22 mai 2026 OSE turns up the heat on ovarian cancer with phase 2, Keytruda-supported win